Summary: A violent confrontation occurred at dawn on Tuesday at the Jordan-Syria border, involving armed Captagon smugglers and Jordanian border guards. The clash resulted in the death of a Jordanian soldier and injuries to another, while several smugglers were killed and others fled into Syria.
Deadly Clash at Jordan-Syria Border: Jordanian Soldier Killed in Captagon Smuggling Incident
The armed confrontation at the northern border of Jordan with Syria involved dozens of armed smugglers who opened fire on Jordanian border guards. According to a report by the Jordanian news agency “Petra,” citing an unnamed military source, the incident led to the death of a Jordanian soldier from the border guard and the injury of another. In response, several Captagon (Fenethylline) smugglers were killed, and the remaining were forced to retreat into Syria.
This incident marks the second armed clash in December, following the Jordanian army’s thwarting of an attempt to smuggle 233,000 Captagon pills, a mixture of amphetamine, and quantities of hashish, on December 5. The Jordanian army has been actively working for years to prevent the smuggling of weapons and drugs across the 375-kilometer Jordan-Syria border.
It is important to note that southern Syria, bordering northern Jordan, is under the full control of Iran and Hezbollah, who are centralizing their drug distribution activities aimed at Gulf countries. Recently, Syrian smuggling networks, under Iranian guidance, have started transferring weapons to terrorists in Judea and Samaria, who are suffering from a severe shortage of weapons and ammunition. Iran’s intention is to ignite tensions across the West Bank, creating another bloody front to engage Israel.
Source: Nziv.net
Subscribe to our weekly newsletter:
We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:
.
.
AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.
